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ABSTRACT:   Introduction: Salivary gland tumours account for 3-6% of tumours of the head and neck. About 80% of salivary gland 
tumors occur in parotid glands, 10-17% of which are malignant  The aim of the study was to assess whether there is an 
upward trend in cancer incidence within the parotid glands, with particular emphasis on cancers.
  Materials and methods: 322 patients underwent surgery and 328 parotid gland tumours were removed in the years 
2005-2014 at the Department of Laryngology and Laryngological Oncology of the Upper Silesian Medical Centre in 
Katowice-Ochojec. Clinical, histopathological and statistical analyses of the removed parotid gland tumours were 
performed.
  Results and discussion: A significant increase in the incidence of benign tumours, especially mixed and Warthin tu-
mours, was demonstrated. There was no significant increase in the number of malignant tumours over the analysed 
period of time.
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INTRODUCTION
Salivary glands may be affected by inflammation, sialolithi-
asis, as well as benign or malignant tumours. Salivary gland 
tumours account for 3-6% of head and neck tumours, 70-85% 
of which are found in the salivary glands. These tumours are 
mostly benign – 80-95%, whereas malignant tumours account 
for 10-17% of cases [1-7]. The 1991 WHO histological classi-
fication lists 32 types of tumours of epithelial glandular tissue 
of the salivary glands in addition to numerous non-epithelial 
tumours, lymphomas and secondary malignancies. From a clin-
ical perspective, it is important whether the malignant tumour 
is low-grade (mucoepidermoid carcinoma and polymorphus 
low-grade adenocarcinoma, acinic cell carcinoma, basal cell 
adenocarcinoma, epithelial-myoepithelial carcinoma, cysto-
carcinoma), intermediate-grade (adenoid cystic carcinoma, 
sebaceous carcinoma, myoepithelial carcinoma, lymphoepi-
thelial carcinoma) or high-grade (squamous cell carcinoma, 
mucoepidermoid high-grade carcinoma, carcinoma ex pleo-
morphic adenoma, salivary duct carcinoma, oncocytic carci-
noma  or adenocarcinoma not otherwise specified). Tumours 
of non-epithelial origin (hemangiomas, lipomas, tumours of 
neurogenic or mesenchymal origin, sarcomas), lymphomas, 
secondary tumours and non-classified tumours may also be 
found within salivary glands.
Histopathological analysis of parotid gland tumours in patients, 
who underwent surgery at the Department of Otolaryngology 
and Laryngological Oncology of the Upper Silesian Medical 
Centre in Katowice-Ochojec in the years 2005-2014, aimed 
to verify the hypothesis whether the upward trend in the inci-
dence of cancer applies to the major salivary glands. We were 
interested in the predominant histopathological type of can-
cer in the parotid glands, as well as any correlations between 
the incidence of cancer and gender, patient age, and side of 
the salivary gland (right vs. left). Attention was focused on the 
time elapsed between detection of the tumor by the patient and 
hospital admission for treatment, clinical stage of the disease, 
presence of facial nerve paralysis before and after surgery, and 
possible cancer recurrence after treatment.
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MATERIALS AND METHODS 
Three hundred and twenty-two patients were treated for the pa-
rotid gland tumour in the years 2005-2014. The operated group 
consisted of 172 women and 150 men aged 21 to 87 years. In 6 
patients, two histologically different tumours were found in the 
removed parotid ands; therefore, 328 tumours were examined 
in the group of 322 patients. All patients underwent surgical 
removal of the parotid gland with identification and preserva-
tion of the facial nerve. The surgical technique was uniform. 
All cases of malignant tumours were subject to detailed anal-
ysis. Clinical staging of the tumour was evaluated according 
to the 2009 TNM classification in accordance with the guide-
lines of the International Union Against Cancer (IUAC) and 
the American Joint Committee of Cancer (AJCC). 
Classification of lymph nodes was based on histopathological 
evaluation. We focused on the time elapsed between the mo-
ment patient noticed the tumour and the moment of surgery 
as well as the presence of facial nerve paralysis before and after 
excision of the salivary gland. Statistical analysis encompassed 
the relationship between tumor incidence and patient gender 
and age. Moreover, we checked whether there was an upward 
trend in the incidence of benign and malignant tumours of the 
examined salivary glands.
RESULTS
As expected, benign tumours predominated in the study ma-
terial, accounting 86.9% (285) of all examined lesions. Malig-
nant tumours were diagnosed in 43 patients representing 13.1% 
of all cases. Warthin tumours (118 cases) and mixed tumours 
(109 cases) clearly prevailed among benign tumours. Detailed 
histopathological analysis of benign tumours identified in the 
removed salivary glands is shown in Table I. 
In five removed salivary glands Warthin tumour was accom-
panied by cystadenoma oncocyticum, basal cell adenoma, and 
in three cases – by a mixed tumour. In 38 salivary glands the 
pathologist confirmed presence of satellite lesions in both re-
moved parotid gland lobes. In 28 salivary glands these lesions 
were benign, whereas malignancy was confirmed in ten. Ma-
lignancy was diagnosed in 27 women and 16 men aged 21-86 
years. Malignant tumours were most often observed in patients 
aged 51 to 69 years (24 out of 43 patients). 
We found 22 and 21 malignant tumours in the right and left 
parotid gland, respectively. In contrast to benign tumours, 
there was no predominance of one histopathological type of a 
tumour. B-cell lymphoma was recognised in 10 cases (23.3%), 
in mucoepidermoid carcinoma in 8 cases (18.6%), and there 
were 7 cases (16.3%) of adenocarcinoma and 5 cases of acinic 
cell carcinoma. The distribution of malignant tumours in the 
parotid salivary glands according to the histopathological type 
of tumour is shown in Table II. 
Twenty patients reported a parotid gland tumour within a one-
year period, 14 patients - between one year and four years, and 
5 patients within twenty-five years  Four people had great dif-
ficulty specifying the duration of the disease. Each case of di-
agnosed malignancy was evaluated. Twelve T1, sixteen T2, ten 
T3 and five T4a tumours were removed. In 12 cases, malignant 
tumours of the salivary glands were accompanied by metastasis 
to regional lymph nodes classified as N1, while no metastat-
ic nodes were found in 27 patients. In two patients, the nodes 
were classified as N2a, and in two others as N2b. Nine of the 
treated patients were in clinical stage I of the disease, stage II 
– 10 patients, stage III – 16 patients and stage IV - 8 patients.
Transient weakness of the superior branches of the facial nerve 
was observed in 2 patients following complete removal of the 
parotid gland due to cancer, while the inferior branches were 
affected in 5 patients. In 8 cases we noted paralysis of all branch-
es of the facial nerve, and in this group the nerve was resected 
deliberately for oncological reasons in one patient.
In order to assess the relationship between the number of tu-
mours and the year, the Spearman’s rank correlation coefficients 
were calculated. Based on the results, it was found that the to-
tal number of tumours increased over the subsequent years 
(r=0.8632, p=0.0013), and in particular there was an increase in 
the incidence of mixed tumour (r=0.7131, p=0.0161) and Warthin 
tumour (r=0.8659, p=0.0012). The total number of tumours also 
rose (p=0.0002), but only an increase in the incidence of benign 
tumours was significant. The correlation for benign tumours was 
r=0.8632 (p=0.0013), while there was no correlation with time 
for malignant tumours (r=0.1896, p=0.5998). Chi-square test 
was applied to assess the differences in the number of tumours 
in subsequent years. No significant differences in the average 
number of malignant tumours over the subsequent years were 
observed, which is consistent with the results obtained from cor-
relation analysis. However, the number of malignant tumours 
is statistically different (p<0.05) from the number of benign tu-
mours in each of the indicated time points.
DISCUSSION
According to the available literature, benign tumours are most 
common in the parotid gland, with a predominance of mixed 
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tumours over lymphadenomas [1, 2]. In some works, this pre-
ponderance is more than double [3-10]. Warthin tumours were 
more often found in our material. This tumour can be multi-
focal [11] and in 3-14% of cases may be found bilaterally [12, 
13]. The main factors affecting the incidence of lymphadenoma 
include long-term smoking [14], ionizing radiation [15] and 
previous infection with the Epstein-Barr virus [16]. 
 Development of a malignant tumour within the lymphadeno-
ma is rare and malignant transformation may involve lymphatic 
stroma giving rise to a lymphoma [17, 18]. Warthin tumour is 
not classified as oncocytic carcinoma, but they two can coexist 
[19]. In our material, in five operated parotid glands Warthin 
tumour coexisted with benign epithelial tumours with onco-
cytic differentiation – cystadenoma oncocyticum.
Malignant tumours of the operated parotid glands, which ac-
counted for 13.1% of the study material, were analysed in de-
tail. In the literature the incidence of malignant parotid gland 
tumours ranges from 10.5% to 25% [7, 15, 20-25]. Among ma-
lignant tumours in adults, the most frequently observed were 
mucoepidermoid carcinoma [8, 24, 28], adenoid cystic carci-
noma [2, 15] and squamous carcinoma [5]. A large retrospec-
tive analysis of 2737 patients in the Netherlands [15] demon-
strated that the incidence of adenoid cystic carcinoma and 
adenocarcinoma was similar (16.5% each). Acinic cell cancer 
was present in 14.78% and mucoepidermoid carcinoma in 
13.6% of patients. In the material obtained from the Taiwanese 
population [1] acinic cell cancer was found most frequently, 
namely in 22.9% of cases.
There are not many cases of B-cell lymphoma described in the 
available literature. The work of Fenstein [29] presents an anal-
ysis of the data acquired over 35 years of observation from the 
National Cancer Institute’s Surveillance, Epidemiology, and 
End Results. Moreover, it describes 2140 patients with prima-
ry parotid gland lymphoma. B-cell lymphomas accounted for 
27.9% of tumours in this group. 
Tab. I.  Benign tumours of the parotid glands operated in the years 2005-2014.
HISTOLOGICAL TYPE OF TUMOUR
YEAR NUMBER OF 
TUMOURS
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
1 mixed tumour 4 11 3 4 15 11 10 18 13 20 109
2 Warthin tumour 7 6 10 8 7 10 11 21 18 20 118
3 basal cell adenoma 1 0 1 0 0 0 1 2 1 0 6
4 cystadenoma oncocyticum 0 0 1 0 1 0 0 2 1 0 5
5 myoepithelioma 0 1 0 0 1 0 0 0 1 1 4
6 lipoma 1 1 1 0 0 0 0 0 2 2 7
7 cyst 0 0 1 1 0 2 0 2 0 3 9
8 pilomatrixoma 0 0 1 0 0 0 0 0 0 0 1
9 lymphoepithelial cyst 0 0 0 0 2 2 0 2 1 0 7
10 fibrosis 0 0 1 0 0 0 0 0 2 0 3
11 melanosis 0 0 1 0 0 0 0 0 0 0 1
12 chronic inflammation 0 1 2 0 0 2 0 0 0 0 5
13 hyalinisiation 0 0 0 0 1 0 0 0 0 0 1
14 atheroma 0 0 0 0 1 0 0 1 0 0 2
15 lymphadenitis chronica 0 0 0 0 0 0 1 1 1 0 3
16 progressive transformation of germinal center 0 0 0 0 0 0 1 0 0 0 1
17 epithelial-myoepithelial carcinoma 0 0 0 0 0 0 0 0 2 0 2
18 monomorphic adenoma 0 0 0 0 0 0 1 0 0 0 1
Total 13 20 22 13 28 27 25 49 42 46 285
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in the number of removed cancers failed to prove unequivo-
cally a statistically significant rise in the number of malignant 
parotid gland tumours.
CONCLUSIONS 
The number of operated tumours of the parotid glands dou-
bled over the years 2012-2014. A significant increase in the 
number of removed malignant tumours was reported in 2014. 
Thirteen tumours were removed, which accounted for 30% of 
malignant tumours operated in the years 2005-2014. The data 
do not permit to conclude that there is a statistically significant 
upward trend in the incidence of malignant parotid gland tu-
mours over the analysed period of time.
We chose the total parotidectomy as the only method of re-
moving parotid gland tumours. The number of detected tu-
mour satellite lesions in both removed lobes of 37 operated 
salivary glands confirmed the validity of this decision. The 
left satellite lesion could be the starting point of another 
cancer, and reoperation of the salivary glands is associated 
with a high risk of damage to the facial nerve. The duration 
of symptoms among our patients was similar to that present-
ed by other authors [7] and lasted for about one year prior to 
entering the hospital. 
The present study recorded and confirmed statistically an over-
all increase in the incidence of parotid gland tumours over 
the analysed years. Other authors operating on large salivary 
glands made similar observations [7, 15, 21, 22]. An increase 
Tabela II. Malignant tumours of the parotid glands operated in the years 2005-2014. 
HISTOLOGICAL TYPE OF TUMOUR
YEAR NUMBER OF 
TUMOURS2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
1 B-cell lymphoma 2 1 1 0 0 1 1 0 0 4 10
2 adenocarcinoma 0 0 0 2 1 0 1 1 0 2 7
3 mucoepidermoid carcinoma 0 2 0 0 0 1 0 0 2 3 8
4 acinic cell carcinoma 1 1 0 0 0 0 0 0 2 1 5
5 clear cell carcinoma 0 0 0 1 0 0 0 0 0 0 1
6 melanotic carcinoma 0 0 0 1 0 0 0 0 0 1 2
7 epithelial-myoepithelial carcinoma 0 1 1 0 0 0 0 0 1 0 3
8 squamous carcinoma 0 1 0 0 0 0 0 0 0 0 1
9 undifferentiated carcinoma 0 0 0 0 0 1 0 0 0 0 1
10 papillary carcinoma 0 0 0 0 0 0 0 1 0 0 1
11 Lymphoepithelial tumour 0 0 0 0 0 0 0 0 1 0 1
12 sarcoma 0 0 0 0 0 0 0 0 1 0 1
13 malignant mixed tumour 0 0 0 0 0 0 0 0 0 2 2
number of malignant tumours 3 6 2 4 1 3 2 1 8 13 43
number of benign tumours 13 20 22 13 28 27 25 49 42 46 285
number of all the removed tumours 16 26 24 17 29 30 27 50 50 59 328
REFERENCES
1. Chan W.H., Lee K.W., Chiang F.Y., Ho K.Y., Chai C.Y., Kuo W.R.: Features of parotid gland diseases and surgical results in southern Taiwan. Kaoh-
siung J. Med. Sci. 2010; 26: 483–492.
2. Fonseca F.P., de Carvalho M.V., de Almeida O.P., Rangel A.L., Takizawa M.C., Bueno A.G., Vargas P.A.: Clinicopathologic analysis of 493 cases of sali-
vary gland tumours in a Southern Brazilian population. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2012; 114: 230–239.
5OTOLARYNGOL POL 2017; 71 (2): ??-??
artykuł oryginalny / original article
3. Gierek T., Majzel K., Witkowski M., Jura-Szołtys E.: Gruczolaki limfatyczne ślinianki przyusznej – analiza 75 przypadków. Otolaryngol. Pol. 2004; 
58: 899–902.
4. Ziółkowska M., Bień S., Okła S., Żyłka S.: Charakterystyka epidemiologiczno-kliniczna 705 nowotworów gruczołów ślinowych. Otolaryngol. Pol. 
2013; 67: 154–163.
5. Żuchnik-Wrona A., Kupisz K.: Guzy ślinianek przyusznych – diagnostyka i leczenie w oparciu o materiał Oddziału Otolaryngologii Chirurgii Głowy 
i Szyi Wojewódzkiego Szpitala Specjalistycznego w Lublinie w latach 2000–2005. Borgis – Nowa Medycyna. 2006; 2: 34–37.
6. Lee Y.M., Choi H.J., Kim J.W., Kim J.H.: Parotid gland tumours in a Korean population. J. Craniofac. Surg. 2012; 23: 205–209.
7. Wierzbicka M., Kopeć T., Szyfter W., Bem G.: Epidemiologia guzów niezłośliwych ślinianek podżuchwowych i przyusznych na podstawie 675 przy-
padków. Otolaryngol. Pol. 2010; 64: 281–287.
8. Tilakaratne W.M., Jayasooriya P.R., Tennakoon T.M., Saku T.: Epithelial salivary tumours in Sri Lanka: a retrospective study of 713 cases. Oral Surg. 
Oral Med. Oral Pathol. Oral Radiol. Endod. 2009; 108: 90–98.
9. Bartkowiak Ł., Przewoźna J., Ryglewicz B., Stefaniak K.: Guzy nowotworowe ślinianek – analiza retrospektywna materiału operacyjnego Kliniki Otola-
ryngologii i Onkologii Laryngologicznej Akademii Medycznej im. Karola Marcinkowskiego w Poznaniu w latach 1995–2002 ze szczególnym uwzględ-
nieniem guzów nawrotowych. Nowiny Lekarskie. 2006; 75: 320–322.
10. Chulam T.C., Noronha Francisco A.L., Goncalves Filho J., Pinto Alves C.A., Kowalski L.P.: Warthin’s tumour of the parotid gland: our experience. 
Acta Otorhinolaryngol. Ital. 2013; 33: 393397.
11. Przewoźny T., Stankiewicz C., Narożny W., Kuczkowski J.: Guz Warthina ślinianki przyusznej. Analiza epidemiologiczno-kliniczna 127 przypadków. 
Otolaryngol. Pol. 2004; 58: 583–591.
12. Przewoźny T., Stankiewicz C., Narożny W., Kuczkowski J.: Obustronny guz Warthina ślinianki przyusznej. Otolaryngol. Pol. 2004; 58: 1203–1209.
13. Bilewicz R., Burduk P.K., Burduk D., Kaźmierczak W.: Mnogie obustronne gruczolaki limfatyczne ślinianek przyusznych. Otolaryngol. Pol. 2006; 60: 
139–142.
14. Yoo G.H., Eisele D.W., Askin F.B., Driben JS, Johns ME.: Warthin’s tumour: a 40-year experience at The Johns Hopkins Hospital. Laryngoscope. 1994; 
104: 799–803.
15. de Ridder M., Balm A.J., Smeele L.E., Wouters M.W., van Dijk B.A.: An epidemiological evaluation of salivary gland cancer in the Netherlands (1989–
2010). Cancer Epidemiol. 2015; 39:14–20.
16. Santucci M., Gallo O., Calzolari A., Bondi R.: Detection of Epstein-Barr viral genome in tumour cells of Warthin’s tumour of parotid gland. Am. J. 
Clin. Pathol. 1993; 100: 662–665.
17. Banik S., Howell J.S., Wright D.H.: Non-Hodgkin’s lymphoma arising in adenolymphoma – A report of two case. J. Pathol. 1985; 146: 167–177.
18. Ferrero S., Cattaneo L., Peri A., Braidotti P. et al.: Poorly differentiated carcinoma arising from adenolymphoma of the parotid gland. BMC Surg. 2003; 
3: 1–5.
19. Zajdel K., Gałązka K., Stachura J., Kurzyński M., Składzień J.: Rozwój niskozróżnicowanego raka w wieloogniskowym guzie Warthina u pacjenta z on-
kocytozą ślinianek przyusznych – opis przypadku. Otorynolaryngologia. 2005; 4: 202–206.
20. Olejniczak I., Kozłowski Z., Dąbrowska K., Łukomski M.: Guzy ślinianki przyusznej – obraz kliniczny, sposób postępowania i wyniki leczenia. Oto-
laryngol. Pol. 2008; 62: 446–450.
21. Suwała P., Wilczyński K., Barnaś S.: Nowotwory ślinianek przyusznych w materiale Klinicznego Oddziału Otolaryngologicznego 4 Wojskowego Szpi-
tala Klinicznego z Polikliniką we Wrocławiu w latach 1992–2010. Otolaryngol. Pol. 2012; 66: 43–45.
22. Kubacka M., Orendorz-Frączkowska K., Pazdro-Zastawny K., Morawska-Kochman M., Kręcicki T.: Ocena epidemiologiczna nowotworów gruczołów 
ślinowych u pacjentów leczonych w Klinice Otolaryngologii we Wrocławiu w latach 2001–2010. Otolaryngol. Pol. 2013; 67: 30–33.
23. Sungur N., Akan I.M., Ulusoy M.G., Ozdemir R., Kilinç H., Ortak T.: Clinicopathological evaluation of parotid gland tumours: a retrospective study. 
J. Craniofac. Surg. 2002; 13: 26–30.
24. Maahs G.S., de Oliviera Oppermann P., Maahs L.G.P, Machado Filho G.M., Ronchi A.D.: Parotid gland tumours: a retrospective study of 154 patients. 
Braz. J. Otorhinolaryngol. 2015; 81: 301–306.
25. Bień S., Ziółkowska M., Kamiński B., Klimas A., Okła S., Postuła S., Żyłka S.: Ocena epidemiologiczna i kliniczna nowotworów gruczołów ślinowych. 
Studia Medyczne Akademii Świętokrzyskiej. 2006; 3: 21–29.
26. Moghadam S.A., Moghadam F.A., Dadfar M.:Epithelial Salivary Gland Tumors in Ahvaz, Southwest of Iran. J. Dent. Res Dent. Clin. Dent Prospects. 
2010; 4: 120–123.
27. Feinstein A.J., Ciarleglio M.M., Cong X., Otremba M.D., Judson B.L.: Parotid gland lymphoma: prognostic analysis of 2140 patients. Laryngoscope. 
2013; 123: 1199–1203.
WWW.OTOLARYNGOLOGYPL.COM6
artykuł oryginalny / original article
Word count: 1800? Tables: 2 Figures: – References: 27
Access the article online: DOI: 10.5604/01.3001.0009.8412 Table of content: http://otolaryngologypl.com/resources/html/articlesList?issueId=9815
Corresponding author: Grażyna Stryjewska-Makuch M.D., Independent Public Research Hospital No. 7 of Silesian Medical University in Katowice, 
Upper Silesian Medical Centre, Department of Laryngology and Laryngological Oncology, ul. Ziołowa 45/47, 40-635 Katowice, Poland,  
tel.+48 32 359 80 00, e-mail:  HYPERLINK „mailto:makuch_mg@wp.pl” makuch_mg@wp.pl
Copyright © 2017 Polish Society of Otorhinolaryngologists  Head and Neck Surgeons. Published by Index Copernicus Sp. z o.o. All rights reserved. 
Competing interests: The authors declare that they have no competing interests.
Cite this article as: Stryjewska-Makuch G, Kolebacz B, Janik M. A., Wolnik A.: Increase in the incidence of parotid gland tumors in the years 2005–2014; Otolaryngol Pol 2017; 71 (2): 
?-??
